SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-071719
Filing Date
2023-08-29
Accepted
2023-08-29 16:01:53
Documents
13
Period of Report
2023-08-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea184389-8k_biomxinc.htm   iXBRL 8-K 33909
  Complete submission text file 0001213900-23-071719.txt   254879

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phgeu-20230828.xsd EX-101.SCH 3934
3 XBRL DEFINITION FILE phgeu-20230828_def.xml EX-101.DEF 26867
4 XBRL LABEL FILE phgeu-20230828_lab.xml EX-101.LAB 37204
5 XBRL PRESENTATION FILE phgeu-20230828_pre.xml EX-101.PRE 25491
7 EXTRACTED XBRL INSTANCE DOCUMENT ea184389-8k_biomxinc_htm.xml XML 5799
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 231221898
SIC: 2836 Biological Products, (No Diagnostic Substances)